ExpiresJune 11, 2020
Oregon Health & Science University School of Medicine
Statistics from 2009-2013 place mortality from HCV 81% higher in Oregon than in the United States as a whole. There still exists a gap both nationally and in Oregon in screening rates for Hepatitis C with a further gap in those diagnosed with Hepatitis C who have access to receive specialist liver care. Prior HCV ECHO programs from both University New Mexico and VA systems have demonstrated expanded capacity for care by local providers equivalent to that which patients would receive from a liver specialist. (Beste et al, 2017; Arora et al, 2010)
ABMS Member Board Approvals by Type
ABMS MOC Part II CME Activity
Psychiatry and Neurology
NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Support participants to develop and sustain systems, protocols, and policies to support hepatitis C treatment in the primary care setting
Understand the populations most at risk for contracting hepatitis C
Increase the number of patients screened for hepatitis B and C with appropriate interpretation of screening tests, as well as best practices for outreach
Promote education for both patients and providers on hepatitis B and C
Promote clinical competence in identification of appropriate hepatitis C treatment candidates and safe treatment with new DAA medications.
Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement, Systems-based Practice
CME Credit Type
AMA PRA Category 1 Credit
Outpatient, Rural, Urban, VA/Military